Functional MRI (fMRI) in CGRP Induced Migraine
In patients known with migraine without aura a migraine headache or migraine like headache will be induced by infusion of calcitonin gene related peptide (CGRP). The patients will then be stimulated with noxious heat via a thermode placed at the forehead. At the same time the Blood-oxygenation-level-dependent (BOLD) response will be measured via functional magnetic resonance imaging (fMRI), to...
Brief Summary
Official Title: “Functional MRI (fMRI) in Patients With Migraine Without Aura Provoked by”
In patients known with migraine without aura a migraine headache or migraine like headache will be induced by infusion of calcitonin gene related peptide (CGRP). The patients will then be stimulated with noxious heat via a thermode placed at the forehead. At the same time the Blood-oxygenation-level-dependent (BOLD) response will be measured via functional magnetic resonance imaging (fMRI), to estimate the central-nervous pain response. The regions of interest (ROI) will be thalamic region and medulla oblongata.
Then the patients will be given pain relif in form of injection of sumatriptan and the effect of this will also be registered via measuring the BOLD response at the RIO's previously defined. A 3-Tesla MRI scanner will be used in this trail.
This study will give us key knowledge of the trigeminal pain pathway and the central processing i.e sensitization during a migraine attach.
- Study Type: Interventional
- Study Design: Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Treatment
- Study Primary Completion Date: July 2007
Intervention(s) in this Clinical Trial
- Drug: infusion of calcitonin gene related peptide (CGRP)
Outcome Measures for this Clinical Trial
Primary Measures
- Changes in BOLD response before and after CGRP infusion.
- Changes in BOLD response before and after injection of sumatriptan.
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Patients know with migraine without aura.
- No less then 1 migraine attach pr month and no more then 6 attaches per month.
- Weight 50-100 kg.
- Women must be using secure birthcontrol.
Exclusion Criteria:
- Tension type headache more then 1 day/month.
- All other prim. og sec. headache types then migraine without aura.
- Daily use of medication other then birthcontrol pills.
- Pregnant and lactation women.
- Headache on the trail day or 5 days previous to the trail day.
- Contraindications to MRI-scans.
- Hypertension or hypotension.
- Known heart or lung condition.
- Mental illness or substance abuse.
- Other considerable conditions judged by the including doctor.
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 55 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Danish Headache Center Other
Overall Clinical Trial Officials and Contacts
Messoud Ashina, MD,PH.d Study Chair Danish Headache Center
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00363532
Study ID Number: KA-20060083
ClinicalTrials.gov Identifier: NCT00363532
Health Authority: Denmark: The Danish National Committee on Biomedical Research Ethics
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00363532
